Krishna Institute of Medical Sciences Limited

As of June 30, 2026, Krishna Institute of Medical Sciences Limited carries a market capitalization of 342.14B, placing it among publicly traded companies globally. Its enterprise value stands at 342.14B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Krishna Institute of Medical Sciences Limited's next confirmed earnings release is scheduled for November 6, 2026.

As of June 30, 2026, Krishna Institute of Medical Sciences Limited has 420.01M shares outstanding.

As of June 30, 2026, Krishna Institute of Medical Sciences Limited trades at a trailing price-to-earnings ratio of 159.70.

As of June 30, 2026, Krishna Institute of Medical Sciences Limited trades at an EV/EBITDA multiple of 41.64 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 8.12 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 69.68 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 342.14B versus a market cap of 342.14B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 3.37M in revenue per employee across its workforce of 12,489.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Krishna Institute of Medical Sciences Limited recorded 824.00M in income tax expense. That works out to an effective tax rate of 29.77, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.77B, leaving 2.04B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Krishna Institute of Medical Sciences Limited's stock has declined approximately 8.07% over the past 52 weeks. The 50-day moving average sits at 755.33, while the 200-day moving average is 723.39.

Over the twelve months ended June 30, 2026, Krishna Institute of Medical Sciences Limited generated 42.13B in revenue and converted that into 2.04B in net income, yielding earnings per share of 4.85. EBITDA reached 8.22B, while operating income came in at 5.02B.

Over the twelve months ended June 30, 2026, Krishna Institute of Medical Sciences Limited posted a gross margin of 70.04, reflecting its pricing power and cost economics. The operating margin of 11.92 and net profit margin of 4.85 provide insight into operational efficiency.

Krishna Institute of Medical Sciences Limited's most recent stock split took place on September 13, 2024 with a 1:5 split ratio.